3.9349
                                            Schlusskurs vom Vortag:
              $3.95
            Offen:
              $3.9
            24-Stunden-Volumen:
                3,250
            Relative Volume:
              0.00
            Marktkapitalisierung:
                $6.44M
            Einnahmen:
              $14.91M
            Nettoeinkommen (Verlust:
              $-3.56M
            KGV:
              -1.60
            EPS:
                -2.4593
            Netto-Cashflow:
                $-1.37M
            1W Leistung:
              +1.94%
            1M Leistung:
              +1.41%
            6M Leistung:
                +3.55%
            1J Leistung:
              +46.82%
            Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Firmenname
                  
                      Sonoma Pharmaceuticals Inc
                    
                Sektor
                  Telefon
                  
                      800-759-9305
                    
                Adresse
                  
                      5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
                    
                Vergleichen Sie SNOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                SNOA
                            
                             Sonoma Pharmaceuticals Inc | 3.92 | 6.52M | 14.91M | -3.56M | -1.37M | -2.4593 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 143.19 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.41 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.245 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.09 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 447.88 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten
Analyzing net buyer seller activity in Sonoma Pharmaceuticals Inc.Weekly Trend Summary & Daily Price Action Insights - newser.com
Is Sonoma Pharmaceuticals Inc. stock gaining market shareQuarterly Performance Summary & Precise Swing Trade Alerts - newser.com
Will Sonoma Pharmaceuticals Inc. (O8Z) stock rise with strong economyOptions Play & AI Powered Market Entry Strategies - newser.com
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zoneDay Trade & Real-Time Price Movement Reports - newser.com
Will Sonoma Pharmaceuticals Inc. stock attract more institutional investors2025 Pullback Review & Stock Portfolio Risk Management - newser.com
How Sonoma Pharmaceuticals Inc. stock benefits from tech adoptionWeekly Earnings Recap & Weekly Breakout Opportunity Watchlist - newser.com
Is Sonoma Pharmaceuticals Inc. stock a dividend growth opportunityGDP Growth & Daily Entry Point Trade Alerts - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock responds to job market shiftsJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Intraday pattern recognizer results for Sonoma Pharmaceuticals Inc.2025 Price Action Summary & Momentum Based Trading Ideas - newser.com
Can Sonoma Pharmaceuticals Inc. (O8Z) stock sustain margin levelsJuly 2025 Summary & Reliable Volume Spike Alerts - newser.com
Why Sonoma Pharmaceuticals Inc. stock is favored by top institutions2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. stock a buy for dividend growth2025 Major Catalysts & Weekly High Return Opportunities - newser.com
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockWeekly Profit Recap & Weekly Watchlist of Top Performers - newser.com
Does Sonoma Pharmaceuticals Inc. stock trade at a discount to peersAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Sentiment analysis tools applied to Sonoma Pharmaceuticals Inc.Global Markets & Real-Time Buy Zone Alerts - newser.com
Predicting Sonoma Pharmaceuticals Inc. trend using moving averagesMarket Risk Analysis & Growth Focused Stock Reports - newser.com
Bull Run: Is Sonoma Pharmaceuticals Inc. (O8Z) stock ideal for retirement investorsWall Street Watch & Reliable Volume Spike Alerts - Fundação Cultural do Pará
What analysts say about Sonoma Pharmaceuticals Inc stockMarket Entry Points & Invest Smarter With Data-Driven Models - earlytimes.in
Will Sonoma Pharmaceuticals Inc. stock attract ESG investorsQuarterly Profit Review & AI Driven Stock Reports - Fundação Cultural do Pará
How analysts revise price targets for Sonoma Pharmaceuticals Inc. (O8Z) stockWeekly Earnings Recap & AI Powered Buy/Sell Recommendations - newser.com
Big Money Moves: What valuation multiples suggest for Sonoma Pharmaceuticals Inc. stockWeekly Investment Summary & Expert Approved Momentum Trade Ideas - Fundação Cultural do Pará
Why Sonoma Pharmaceuticals Inc. stock appeals to analysts2025 Bull vs Bear & Detailed Earnings Play Strategies - Fundação Cultural do Pará
Sonoma Pharmaceuticals terminates COO ‘for cause’ - BizWest
Aug Sectors: How Sonoma Pharmaceuticals Inc. stock reacts to job market dataEarnings Overview Report & Daily Price Action Insights - Fundação Cultural do Pará
Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App